• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.

作者信息

Billany Roseanne E, Selvaskandan Haresh, Adenwalla Sherna F, Hull Katherine L, March Daniel S, Burton James O, Bishop Nicolette C, Carr Edward J, Beale Rupert, Tang Julian W, Bird Paul W, Holmes Chris W, Baines Richard, Brunskill Nigel J, Graham-Brown Matthew P M

机构信息

Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Cardiovascular Biomedical Research Centre, Glenfield Hospital Leicester, Leicester, UK; John Walls Renal Unit, University Hospitals Leicester National Health Service Trust, Leicester, UK.

Department of Cardiovascular Sciences, University of Leicester and National Institute for Health Research Leicester Cardiovascular Biomedical Research Centre, Glenfield Hospital Leicester, Leicester, UK.

出版信息

Kidney Int. 2021 Jun;99(6):1492-1494. doi: 10.1016/j.kint.2021.04.008. Epub 2021 Apr 20.

DOI:10.1016/j.kint.2021.04.008
PMID:33887316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8055918/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8953/8055918/4186039cc0b9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8953/8055918/4186039cc0b9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8953/8055918/4186039cc0b9/gr1_lrg.jpg

相似文献

1
Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.接受血液透析的患者接种新冠疫苗后针对S1刺突蛋白抗体的血清流行率：紧急呼吁
Kidney Int. 2021 Jun;99(6):1492-1494. doi: 10.1016/j.kint.2021.04.008. Epub 2021 Apr 20.
2
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.美国接受透析治疗患者中新冠病毒 2 型抗体血清流行率
Lancet. 2020 Oct 24;396(10259):1308-1309. doi: 10.1016/S0140-6736(20)32006-7. Epub 2020 Sep 25.
3
SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.血液透析人群中针对严重急性呼吸综合征冠状病毒2的细胞免疫和体液免疫
Kidney Int. 2021 Jun;99(6):1489-1490. doi: 10.1016/j.kint.2021.03.032. Epub 2021 Apr 20.
4
SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.用于血清流行病学的 SARS-CoV-2 特异性抗体检测：一种考虑准确血清流行率的多重分析方法。
J Infect Dis. 2020 Oct 1;222(9):1452-1461. doi: 10.1093/infdis/jiaa479.
5
Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.母亲在确诊 COVID-19 PCR、出现病毒症状且未暴露于病毒的情况下，母乳中针对 SARS-CoV-2、HCoV-OC43 和 HCoV-229E 的 S1 和 S2 亚单位的人乳抗体。
Int J Mol Sci. 2021 Feb 9;22(4):1749. doi: 10.3390/ijms22041749.
6
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。
CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.
7
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.SARS-CoV-2 血清阳性率调查估计受到核衣壳抗体下降的影响。
J Infect Dis. 2021 Apr 23;223(8):1334-1338. doi: 10.1093/infdis/jiaa796.
8
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.非重症 COVID-19 患者中持续的 SARS-CoV-2 核衣壳抗体水平：一项基于人群的研究。
Clin Chem Lab Med. 2020 Nov 19;59(2):e49-e51. doi: 10.1515/cclm-2020-1347.
9
Methods matter - Tailoring SARS-CoV-2 antibody targets to vaccination status.方法很重要——根据疫苗接种状况定制针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体靶点。
Clin Chim Acta. 2021 Aug;519:140-141. doi: 10.1016/j.cca.2021.04.009. Epub 2021 Apr 17.
10
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.抗体介导的 SARS-CoV-2 刺突糖蛋白结构破坏。
Nat Commun. 2020 Oct 21;11(1):5337. doi: 10.1038/s41467-020-19146-5.

引用本文的文献

1
Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms.在使用不同疫苗平台对血液透析患者进行免疫接种后，针对同一抗原可诱导出不同的中和抗体和补体结合抗体反应。
Vaccines (Basel). 2024 Dec 25;13(1):7. doi: 10.3390/vaccines13010007.
2
Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review.2019冠状病毒病疫苗接种与糖尿病之间的相关性：一项系统综述。
World J Diabetes. 2023 Jun 15;14(6):892-918. doi: 10.4239/wjd.v14.i6.892.
3
Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature.
新冠病毒mRNA疫苗接种后血液透析患者的体液免疫反应：文献系统综述
Vaccines (Basel). 2023 Mar 24;11(4):724. doi: 10.3390/vaccines11040724.
4
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.免疫抑制治疗和新型冠状病毒2型疫苗类型对慢性肾脏病或肾脏替代治疗患者三次接种疫苗后抗体水平的影响
Clin Kidney J. 2022 Nov 24;16(3):528-540. doi: 10.1093/ckj/sfac249. eCollection 2023 Mar.
5
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients.日本血液透析患者接种BNT162b2疫苗后的体液免疫反应。
Ren Replace Ther. 2023;9(1):13. doi: 10.1186/s41100-022-00452-1. Epub 2023 Feb 20.
6
Clinical features, management and outcomes of peritoneal dialysis patients during Delta and Omicron waves of COVID-19 infections.COVID-19 感染的德尔塔和奥密克戎波期间腹膜透析患者的临床特征、管理和结局。
Int Urol Nephrol. 2023 Aug;55(8):2075-2081. doi: 10.1007/s11255-023-03496-2. Epub 2023 Feb 23.
7
Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis.营养不良与血液透析患者对 SARS-CoV-2 疫苗反应的相关性。
Clin Nutr. 2022 Dec;41(12):2683-2690. doi: 10.1016/j.clnu.2022.10.011. Epub 2022 Oct 19.
8
Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.血液透析患者中 SARS-CoV-2 疫苗的免疫原性和安全性：系统评价和荟萃分析。
Front Public Health. 2022 Sep 23;10:951096. doi: 10.3389/fpubh.2022.951096. eCollection 2022.
9
The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients.血液透析患者对基于载体的SARS-CoV-2疫苗体液反应的消长及预测因素
Vaccines (Basel). 2022 Sep 15;10(9):1537. doi: 10.3390/vaccines10091537.
10
Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study.AZD1222新冠疫苗在透析患者中的抗体反应及不良事件：一项前瞻性队列研究
Vaccines (Basel). 2022 Sep 3;10(9):1460. doi: 10.3390/vaccines10091460.